{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:42:14Z","timestamp":1792622534468,"version":"4.5.0"},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to investigate the association between hepatic steatosis and serum levels of reproductive hormones in premenopausal women, with particular focus on progesterone and prolactin. A total of 87 premenopausal women aged 18\u201345 years were included in this prospective study. Participants were classified by ultrasonographic steatosis status and grade. Blood samples obtained on day 3 of the menstrual cycle were used to measure follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, and prolactin levels. Women with overt metabolic and endocrine disorders were excluded. Multivariable logistic regression and receiver operating characteristic analyses were performed. Hepatic steatosis was present in 53 participants (60.9%), whereas 34 participants had no steatosis. Progesterone and prolactin levels were significantly lower in participants with hepatic steatosis than in those without steatosis (0.6 vs. 1.1 ng\/mL and 7.9 vs. 11.0 ng\/mL, respectively; both p&lt;0.001). In multivariable analysis, older age (odds ratio: 1.32, 95% confidence interval: 1.12\u20131.56; p=0.001), higher body mass index (odds ratio: 1.57, 95% confidence interval: 1.19\u20132.08; p=0.002), lower progesterone levels (odds ratio: 0.75, 95% confidence interval: 0.58\u20130.98; p=0.037), and lower prolactin levels (odds ratio: 0.51, 95% confidence interval: 0.34\u20130.79; p=0.002) were independently associated with hepatic steatosis. Estradiol, follicle-stimulating hormone, and luteinizing hormone were not associated with steatosis. Receiver operating characteristic analysis showed a discriminative value for progesterone (area under the curve: 0.751) and prolactin (area under the curve: 0.790). Lower serum progesterone and prolactin levels were associated with hepatic steatosis after adjustment for age and body mass index. These findings support a possible relationship between reproductive hormonal milieu and hepatic steatosis in a selected premenopausal population, while the progesterone finding should be interpreted in the context of early follicular-phase measurement.<\/jats:p>","DOI":"10.1055\/a-2949-7994","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:45:16Z","timestamp":1789188316000},"page":"413-418","source":"Crossref","is-referenced-by-count":0,"title":["Association of Progesterone and Prolactin with Hepatic Steatosis in Premenopausal Women: A Prospective Cross-Sectional Study"],"prefix":"10.1055","volume":"58","author":[{"given":"Muhammed Aziz","family":"Ulusoy","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4977-9919","authenticated-orcid":false,"given":"Mustafa","family":"Comoglu","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguzhan","family":"Zengin","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Camli","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma Andac","family":"Uzdogan","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Ankara, Turkey","place":["\u00c7ankaya"],"department":["Department of Medical Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emra Asfuroglu","family":"Kalkan","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Ates","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital, Turkey","place":["\u00c7ankaya"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"100835","DOI":"10.1016\/j.jhepr.2023.100835","article-title":"Non-alcoholic fatty liver disease in women\u2013current knowledge and emerging concepts","volume":"5","author":"P C Eng","year":"2023","journal-title":"JHEP Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40618-022-01766-x","article-title":"Non-alcoholic fatty liver disease through the female lifespan: The role of sex hormones","volume":"45","author":"K Pafili","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"J Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"B T Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.dld.2021.05.022","article-title":"Association of sex hormones with hepatic steatosis in men with chronic hepatitis B","volume":"54","author":"Q Chen","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/a-2043-1044","article-title":"Prolactin is a key factor for nonalcoholic fatty liver disease in obese children","volume":"55","author":"J Zhang","year":"2023","journal-title":"Hormone Metab Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1002320","DOI":"10.3389\/fendo.2022.1002320","article-title":"Metabolic effects of prolactin and the role of dopamine agonists: A review","volume":"13","author":"P Kirsch","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jgh.13271","article-title":"Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old","volume":"31","author":"N Wang","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"113757","DOI":"10.1016\/j.fct.2023.113757","article-title":"Olanzapine-induced nonalcoholic fatty liver disease: the effects of differential food pattern and the involvement of PGRMC1 signaling","volume":"176","author":"Z Zhu","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15711","DOI":"10.1038\/s41598-018-34148-6","article-title":"Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis","volume":"8","author":"S R Lee","year":"2018","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062252","article-title":"Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A retrospective analysis of patients from a single hospital in China","volume":"12","author":"Y Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"P Zhang","year":"2018","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12876-019-1120-z","article-title":"A newly noninvasive model for prediction of non-alcoholic fatty liver disease: Utility of serum prolactin levels","volume":"19","author":"P Zhang","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s12876-022-02619-w","article-title":"Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: A retrospective cohort study","volume":"22","author":"P Xu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"815995","DOI":"10.3389\/fendo.2022.815995","article-title":"J-shaped relationship between serum prolactin and metabolic-associated fatty liver disease in female patients with type 2 diabetes","volume":"13","author":"C Zhu","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/liv.15866","article-title":"Association of sex hormones with non-alcoholic fatty liver disease: An observational and Mendelian randomization study","volume":"44","author":"C Weng","year":"2024","journal-title":"Liver Int"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in postmenopausal women: Implications for diagnosis and treatment","volume":"161","author":"J K DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0236506","DOI":"10.1371\/journal.pone.0236506","article-title":"Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer","volume":"15","author":"J-J Yoo","year":"2020","journal-title":"PloS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"116281","DOI":"10.1016\/j.biopha.2024.116281","article-title":"Progesterone increases hepatic lipid content and plasma lipid levels through PR-B-mediated lipogenesis","volume":"172","author":"K J Jeong","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/ars.2021.0044","article-title":"Sex differences in nonalcoholic fatty liver disease: estrogen influence on the liver\u2013adipose tissue crosstalk","volume":"35","author":"A Mor\u00e1n-Costoya","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12902-023-01427-x","article-title":"Follicle-stimulating hormone is negatively associated with nonalcoholic fatty liver disease in a Chinese elderly population: A retrospective observational study","volume":"23","author":"X Li","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/1753-0407.13394","article-title":"Association between follicle-stimulating hormone and nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus","volume":"15","author":"S Ge","year":"2023","journal-title":"J Diabetes"},{"key":"ref23","first-page":"725","article-title":"The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS","volume":"11","author":"Z Qu","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"H V\u00f6lzke","year":"2007","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/dme.13565","article-title":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: Evaluation of their application in people with Type 2 diabetes","volume":"35","author":"A Sberna","year":"2018","journal-title":"Diabetic Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Z M Younossi","year":"2025","journal-title":"Clin Mol Hepatol"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2949-7994.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:37:20Z","timestamp":1792622240000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2949-7994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,21]]},"published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2949-7994","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}